Industry Favors Predictability Over Speed In Next Round Of MDUFMA
This article was originally published in The Gray Sheet
Executive Summary
Senior device industry staffers are more interested in improving the predictability of FDA's premarket review process than pushing the agency to accelerate its performance, an FDA 1report suggests
You may also be interested in...
Survey Suggests Industry Aversion To Facility Registration Fee
More than 60% of 21 medical device firms surveyed last year opposed the idea of an FDA facility Registration fee as an alternative to premarket submission fees, according to a 1report issued May 23
Survey Suggests Industry Aversion To Facility Registration Fee
More than 60% of 21 medical device firms surveyed last year opposed the idea of an FDA facility Registration fee as an alternative to premarket submission fees, according to a 1report issued May 23
MDUFMA Reauthorization Agreement Is In Place – AdvaMed
The medical device industry has reached an agreement with FDA on what will be included in updated user fee legislation, according to AdvaMed President Steve Ubl